The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Aldactone 25 mg Film-coated Tablets

25 milligram(s) Film-coated tablet

Primecrown 2010 LimitedPPA1633/030/001

Main Information

Trade NameAldactone 25 mg Film-coated Tablets
Active SubstancesSpironolactone
Strength25 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderPrimecrown 2010 Limited
Licence NumberPPA1633/030/001

Group Information

ATC CodeC03DA Aldosterone antagonists
C03DA01 spironolactone


Licence Issued13/09/2013
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back